Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Afatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 32 Neoplasms 8 Breast Neoplasms 8 Head and Neck Neoplasms 4 Lung Neoplasms 3 Carcinoma, Squamous Cell 3 Adenocarcinoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thoracic Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Cancers of the Head and Neck 1 Rhabdomyosarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Neuroectodermal Tumors 1 Neoplasms by Site 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1

Interventions

Cyclophosphamide 39 fludarabine phosphate 38 fludarabine 35 Imatinib Mesylate 33 Whole-Body Irradiation 31 Mycophenolic Acid 29 nilotinib 28 Tacrolimus 23 Busulfan 20 Cyclosporine 16 thymoglobulin 15 Melphalan 14 Granulocyte Colony-Stimulating Factor 14 Dasatinib 14 Antilymphocyte Serum 14 Thiotepa 12 Peripheral Blood Stem Cell Transplantation 12 Filgrastim 11 bosutinib 10 Stem Cell Transplantation 10 Methotrexate 10 ponatinib 8 Cord Blood Stem Cell Transplantation 8 sargramostim 7 Rituximab 7 Cytarabine 7 Cyclosporins 7 Clofarabine 6 plerixafor 5 Sirolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡